Skip to content
10-Q

Quarterly Report

Krystal Biotech, Inc. KRYS

0001711279-25-000087

← back to feed
Filed
Nov 3, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 29, 2025 29M sh
Shares Diluted Q3 2025 · Sep 30, 2025 29.83M sh
Shares Diluted Q3 2025 · Sep 30, 2025 29.83M sh
Shares Diluted Q3 2025 · Sep 30, 2024 29.9M sh
Shares Diluted Q3 2025 · Sep 30, 2024 29.67M sh
Capex Q3 2025 · Sep 30, 2025 $9.81M
Capex Q3 2025 · Sep 30, 2024 $3.44M
Operating Cash Flow Q3 2025 · Sep 30, 2025 $123.36M
Operating Cash Flow Q3 2025 · Sep 30, 2024 $70.58M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $392.6M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $344.87M
Stockholders Equity Q3 2025 · Sep 30, 2025 $1.14B
Stockholders Equity Q3 2025 · Jun 30, 2025 $1.04B
Stockholders Equity Q3 2025 · Mar 31, 2025 $984.67M
Stockholders Equity Q3 2025 · Dec 31, 2024 $946.38M
Stockholders Equity Q3 2025 · Sep 30, 2024 $885.85M
Stockholders Equity Q3 2025 · Jun 30, 2024 $838.89M
Stockholders Equity Q3 2025 · Mar 31, 2024 $799.24M
Stockholders Equity Q3 2025 · Dec 31, 2023 $778.64M
Current Liabilities Q3 2025 · Sep 30, 2025 $91.27M
Current Liabilities Q3 2025 · Dec 31, 2024 $102M
Total Liabilities Q3 2025 · Sep 30, 2025 $102.22M
Total Liabilities Q3 2025 · Dec 31, 2024 $109.46M
Current Assets Q3 2025 · Sep 30, 2025 $925.65M
Current Assets Q3 2025 · Dec 31, 2024 $742.05M
Total Assets Q3 2025 · Sep 30, 2025 $1.24B
Total Assets Q3 2025 · Dec 31, 2024 $1.06B
Eps Diluted Q3 2025 · Sep 30, 2025 $2.66
Eps Diluted Q3 2025 · Sep 30, 2025 $5.14
Eps Diluted Q3 2025 · Sep 30, 2024 $0.91
Eps Diluted Q3 2025 · Sep 30, 2024 $1.47
Eps Basic Q3 2025 · Sep 30, 2025 $2.74
Eps Basic Q3 2025 · Sep 30, 2025 $5.31
Eps Basic Q3 2025 · Sep 30, 2024 $0.95
Eps Basic Q3 2025 · Sep 30, 2024 $1.53
Sga Expense Q3 2025 · Sep 30, 2025 $37.58M
Sga Expense Q3 2025 · Sep 30, 2025 $105.29M
Sga Expense restated Q3 2025 · Sep 30, 2024 $28.67M
Sga Expense restated Q3 2025 · Sep 30, 2024 $82.34M
Rd Expense Q3 2025 · Sep 30, 2025 $14.59M
Rd Expense Q3 2025 · Sep 30, 2025 $43.25M
Rd Expense restated Q3 2025 · Sep 30, 2024 $13.51M
Rd Expense restated Q3 2025 · Sep 30, 2024 $40.05M
Net Income Q3 2025 · Sep 30, 2025 $79.37M
Net Income Q3 2025 · Sep 30, 2025 $153.43M
Net Income Q3 2025 · Jun 30, 2025 $38.33M
Net Income Q3 2025 · Mar 31, 2025 $35.73M
Net Income Q3 2025 · Sep 30, 2024 $27.18M
Net Income Q3 2025 · Sep 30, 2024 $43.68M
Net Income Q3 2025 · Jun 30, 2024 $15.57M
Net Income Q3 2025 · Mar 31, 2024 $932K
Operating Income Q3 2025 · Sep 30, 2025 $41.37M
Operating Income Q3 2025 · Sep 30, 2025 $117.03M
Operating Income restated Q3 2025 · Sep 30, 2024 $22.47M
Operating Income restated Q3 2025 · Sep 30, 2024 $24.37M
Revenue Q3 2025 · Sep 30, 2025 $97.8M
Revenue Q3 2025 · Sep 30, 2025 $282.03M
Revenue Q3 2025 · Sep 30, 2024 $83.84M
Revenue Q3 2025 · Sep 30, 2024 $199.38M